ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0400

Thresholds of Presenteeism Measurement Instruments for Unacceptable Work Participation and Future Adverse Work Outcomes in Rheumatoid Arthritis

Dafne Capelusnik1, Sofia Ramiro2, Elena Nikiphorou3, Walter P. Maksymowych4, Marina Nighat Magrey5, Helena Marzo-Ortega6 and Annelies Boonen7, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3King's College London, London, United Kingdom, 4University of Alberta, Edmonton, AB, Canada, 5Case Western Reserve University, University Hospitals, Cleveland, OH, 6NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

Meeting: ACR Convergence 2023

Keywords: Outcome measures, pain, rheumatoid arthritis, work

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: (0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Presenteeism is associated with lower work satisfaction and increased risk of future sick leave in rheumatic diseases. It is generally measured on a continuous scale; however, despite a lower precision, identifying persons with a meaningful level of presenteeism can improve interpretation in clinical studies and might be useful in routine practice. Recently, thresholds of meaning for presenteeism instruments were established for axial spondyloarthritis (axSpA). Our objectives were 1) To identify thresholds for presenteeism instruments that reflect unacceptable work status in patients with RA and whether those thresholds could predict future adverse work outcomes; 2) to assess in patients with RA the performance of presenteeism thresholds previously established in axSpA for the same instruments.

Methods: We used data from the 1-year multinational prospective study on Patient-Reported Outcomes in Employment Study in Rheumatoid Arthritis (RA-PROSE). Thresholds to determine when patients consider themselves in unacceptable work status were calculated at baseline for 4 presenteeism instruments (Work Productivity and Activity Impairment questionnaire -WPAI-, Quality and Quantity method -QQ-, Workplace Activity Limitations Scale -WALS- and Work Limitations Questionnaire -WLQ 25-) and for a patient global assessment of pain.

We created receiver operating characteristic (ROC) using as external criterion addressing one’s ability to perform current job satisfactorily. We used different approaches (75th percentile, Youden index, Liu method, nearest to 0.1) to determine the optimal cut-off, while balancing over-under diagnosis (i.e. specificity and sensitivity). Next, accuracy of thresholds to predict future adverse work outcome (AWO) throughout 12 months (defined as sick leave or long-term disability) was assessed. The recently developed presenteeism thresholds for axSpA were also tested.

Results: 105 employed patients were included: 77% females, mean age 48 (SD 9), with a symptom duration of 9.8 (8.7) years. 15% of the patients considered themselves in an unacceptable work status and 7 (8%) had at least one AWO during the 12 months.

All instruments showed good performance vs the external criterion (AUC >0.75) except for the QQ method (AUC 0.62) (figure). The table shows for each instrument (presenteeism and pain) the optimal thresholds and their performance to correctly identify an unacceptable work status and AWO during 12 months for the RA-specific threshold (1st row) and the available axSpA threshold (2nd row). Interestingly, the axSpA thresholds performed better to classify work status as unacceptable and to predict AWO (somewhat lower sensitivity but higher % of correctly classified patients). For adverse work outcome over 12 months, pain and WPAI performed better especially in predicting AWO.

Conclusion: Thresholds for presenteeism and pain representing unacceptable work status have been established for RA. Previously developed thresholds for axSpA showed an even better performance and are therefore the preferred to be used. WPAI performed the best and can be used to identify patients requiring more tailored care in order to avoid future AWO.

Supporting image 1

Supporting image 2

Figure. ROC curves for presenteeism (4 different measurement instruments) and for pain according to unacceptable work status.


Disclosures: D. Capelusnik: None; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, Galapagos, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, UCB Pharma, 2, 5; E. Nikiphorou: AbbVie/Abbott, 6, Celltrion, 6, Eli Lilly, 6, fresenius, 6, Galapagos, 6, Gilead, 1, 6, Pfizer, 6, Sanofi, 6; W. Maksymowych: AbbVie, 2, 5, 6, BMS, 2, 6, Boehringer-Ingelheim, 2, CARE Arthritis Ltd, 4, CARE Arthritis Ltd., 4, Celgene, 2, 6, Eli Lilly, 2, 6, Galapagos, 2, 6, Gilead, 2, Janssen, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6; M. Magrey: AbbVie, 2, Bristol Myers Squibb, 2, Eli Lilly, 2, Novartis, 2, Pfizer Inc, 2, UCB, 5; H. Marzo-Ortega: AbbVie, 2, 6, Biogen, 2, 6, Eli Lilly, 2, 6, Janssen, 2, 5, 6, MoonLake, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 6, Takeda, 2, 6, UCB Pharma, 2, 5, 6; A. Boonen: AbbVie, 2, 5, 6, Galapagos, 2, 6, Novartis, 2, 6, Pfizer, 5, 6, UCB Pharma, 2, 6.

To cite this abstract in AMA style:

Capelusnik D, Ramiro S, Nikiphorou E, Maksymowych W, Magrey M, Marzo-Ortega H, Boonen A. Thresholds of Presenteeism Measurement Instruments for Unacceptable Work Participation and Future Adverse Work Outcomes in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/thresholds-of-presenteeism-measurement-instruments-for-unacceptable-work-participation-and-future-adverse-work-outcomes-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/thresholds-of-presenteeism-measurement-instruments-for-unacceptable-work-participation-and-future-adverse-work-outcomes-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology